Neuro-Oncology Reviews
Volume
28 Number 2
20 January 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 2, 20 January
Viani GA, Hamamura AC, Arruda CV, Cardoso CE, Salmon HA, Amaral
GO.
Children's outcomes in
medulloblastoma proton versus photon craniospinal radiotherapy
(CURE): meta-analysis.
Radiother
Oncol. 2026 Jan 11:111367. doi:
10.1016/j.radonc.2026.111367. PMID:
41529731. Review; Meta-analysis˰
ˍ
Jadoon S, Solou M, Moussa AA, Zisakis A.
Intracranial
primary collision tumours: A comprehensive systematic review on
preoperative radiological accuracy and neuro-oncological insights.
Brain
Spine. 2026 Jan 12;6:105943. doi:
10.1016/j.bas.2026.105943. PMID:
41584996. Review. ˍ
Shao D, Lou S, Liu Y, Kou Z.
Artificial
intelligence in glioma research: a bibliometric analysis of global
trends, hotspots, and future directions.
Front
Neurol. 2026 Jan 12;16:1701499. doi:
10.3389/fneur.2025.1701499. PMID:
41603012. Bibliometric analysis. ˍ
Shireman JM, Ammanuel S, Cheng L, Distler E, Tao Y, Kendziorski C,
Dey M.
Glioblastoma immunotherapy in
the context of the aging immune system: a systematic review and
meta-analysis.
J
Neurooncol. 2026 Jan 12;176(2):164. doi:
10.1007/s11060-025-05395-1. PMID:
41524915. Review; Meta-analysis.
ˍ
Baby MV, Narendranath RM, Kaur-Paneser S, Ramsay DSC, Ponniah HS,
Namireddy SR, Salih A, Thavarajasingam A, Scurtu D, Kramer A,
Stöcklein V, Kalasauskas D, Jankovic D, Ringel F,
Thavarajasingam SG.
Determinants of
survival after re-resection for recurrent glioblastoma: a
meta-analysis.
Acta
Neurochir (Wien). 2026 Jan 13;168(1):11. doi:
10.1007/s00701-025-06755-6. PMID:
41530365. Meta-analysis. ˍ
T-Ardah M, Malathi H, Maharana L, Dhyani A, Al-Hasnaawei S,
Singh-Chauhan A, Arora V, Sharma J, Kumar-Mishra M.
Stem
Cell-Based Delivery of Immunomodulators for Overcoming
Glioblastoma Immune Evasion.
Immunology.
2026 Jan 13. doi:
10.1111/imm.70102. PMID:
41531107. Review. ˍ
Dynarowicz K, Smolak B, Bartusik-Aebisher D, Guz W, Henrykowska G,
Aebisher D.
Current
Pharmacotherapeutic Strategies in Diffuse Gliomas: Focus on
Glioblastoma, IDH-Wildtype, and Emerging Targeted Therapies for
IDH-Mutant Tumors.
Pharmaceuticals
(Basel). 2026 Jan 14;19(1):148. doi:
10.3390/ph19010148. PMID:
41599746. Review. ˍ
Kim DJ.
Molecular and Immune
Mechanisms Governing Cancer Metastasis, Including Dormancy,
Microenvironmental Niches, and Tumor-Specific Programs.
Int
J Mol Sci. 2026 Jan 15;27(2):875. doi:
10.3390/ijms27020875. PMID:
41596524. Review. ˍ
Dabbagh Ohadi MA, Soleimani S, Kakoienejad MM, Ghasemi M,
Hadjipanayis CG.
Clinical benefits of
photodynamic therapy in glioblastoma: systematic review and
meta-analysis.
J
Neurosurg. 2026 Jan 16:1-11. doi:
10.3171/2025.8.JNS25763. PMID:
41569684. Review; Meta-analysis˰
ˍ
Fiallo Arroyo J, Leon-Rojas JE.
The
Glymphatic-Immune Axis in Glioblastoma: Mechanistic Insights and
Translational Opportunities.
Int
J Mol Sci. 2026 Jan 16;27(2):928. doi:
10.3390/ijms27020928. PMID:
41596575. Review. ˍ
Mackall C.
CAR T cells: the missing
piece needed to improve outcomes for children with cancer?
J
Immunother Cancer. 2026 Jan 16;14(1):e013325. doi:
10.1136/jitc-2025-013325. PMID:
41545304. Perspective. ˍ
Rubio C, Pérez-Villavicencio J, Esteban-Román NF,
Lee Á, Reyes-Soto G, Rubio-Osornio M.
The
Extracellular Matrix, the Silent 'Architect' of Glioma.
Biomedicines.
2026 Jan 17;14(1):205. doi:
10.3390/biomedicines14010205. PMID:
41595739. Review. ˍ
Kokossis D, Mian A, Crumley B, Dahiya S, Abdelbaki MS.
Pediatric
High-Grade Astrocytoma With Piloid Features: A Comprehensive
Literature Review.
Pediatr
Blood Cancer. 2026 Jan 18:e70072. doi:
10.1002/1545-5017.70072. PMID:
41549586. Review˰ ˍ
Tardito S, Haydar D, Cao Y.
Editorial:
Strategies aimed at improving the effectiveness of immunotherapies
in pediatric brain cancer.
Front
Immunol. 2026 Jan 19;16:1771946. doi:
10.3389/fimmu.2025.1771946. PMID:
41635844. Editorial. ˍ